東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Treatment of autism spectrum disorde...

Ham, Hannah L.

Linked to FindBook

Google Book

Amazon

博客來

Treatment of autism spectrum disorder within a Medicaid-enrolled pediatric sample: Prevalence and predictors of psychopharmacological treatment.

Record Type:	Electronic resources : Monograph/item
Title/Author:	Treatment of autism spectrum disorder within a Medicaid-enrolled pediatric sample: Prevalence and predictors of psychopharmacological treatment./
Author:	Ham, Hannah L.
Description:	171 p.
Notes:	Source: Dissertation Abstracts International, Volume: 77-10(E), Section: B.
Contained By:	Dissertation Abstracts International77-10B(E).
Subject:	Clinical psychology. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=10109765
ISBN:	9781339730349

Treatment of autism spectrum disorder within a Medicaid-enrolled pediatric sample: Prevalence and predictors of psychopharmacological treatment.
Ham, Hannah L.

Treatment of autism spectrum disorder within a Medicaid-enrolled pediatric sample: Prevalence and predictors of psychopharmacological treatment. - 171 p.

Source: Dissertation Abstracts International, Volume: 77-10(E), Section: B.

Thesis (Ph.D.)--Michigan State University, 2016.

The purpose of this study was to contribute to the literature on the prevalence of psychotropic medications for youth with autism spectrum disorder within a sample of Medicaid-enrolled children and adolescents (N = 8,058) in the state of Michigan in the year 2009. Prevalence of psychopharmacological treatments, rates of polypharmacy, and the predictive value of participant, educational, and healthcare characteristics were analyzed. Results indicated that 60% of participants were prescribed a psychotropic medication, and approximately 36% received polypharmacy intervention. Older age, identifying as White, having an Asperger's diagnosis, and receiving a comorbid diagnosis were found to be associated with an increased likelihood of being prescribed psychopharmacologic intervention. County educational characteristics, specifically total number of students and student-teacher ratio, were also found to influence psychopharmacologic prescribing. Lastly, a dramatic increase in prevalence rates was identified between 2001 (32%) and 2009 (60%) for youth with autism spectrum disorder. In summary, psychopharmacologic prevalence doubled during the targeted decade in the state of Michigan, and variables outside of the scope of medical best practice were found to influence psychopharmacologic prescribing practices. Implications of study findings on future research are discussed.

ISBN: 9781339730349Subjects--Topical Terms:

524863
Clinical psychology.

Treatment of autism spectrum disorder within a Medicaid-enrolled pediatric sample: Prevalence and predictors of psychopharmacological treatment.
LDR:02330nmm a2200277 4500 001 2074316
005 20160926125811.5
008 170521s2016 ||||||||||||||||| ||eng d
020 $a 9781339730349
035 $a (MiAaPQ)AAI10109765
035 $a AAI10109765
040 $a MiAaPQ $c MiAaPQ
100 1 $a Ham, Hannah L. $3 3189615
245 1 0 $a Treatment of autism spectrum disorder within a Medicaid-enrolled pediatric sample: Prevalence and predictors of psychopharmacological treatment.
300 $a 171 p.
500 $a Source: Dissertation Abstracts International, Volume: 77-10(E), Section: B.
500 $a Adviser: John Carlson.
502 $a Thesis (Ph.D.)--Michigan State University, 2016.
520 $a The purpose of this study was to contribute to the literature on the prevalence of psychotropic medications for youth with autism spectrum disorder within a sample of Medicaid-enrolled children and adolescents (N = 8,058) in the state of Michigan in the year 2009. Prevalence of psychopharmacological treatments, rates of polypharmacy, and the predictive value of participant, educational, and healthcare characteristics were analyzed. Results indicated that 60% of participants were prescribed a psychotropic medication, and approximately 36% received polypharmacy intervention. Older age, identifying as White, having an Asperger's diagnosis, and receiving a comorbid diagnosis were found to be associated with an increased likelihood of being prescribed psychopharmacologic intervention. County educational characteristics, specifically total number of students and student-teacher ratio, were also found to influence psychopharmacologic prescribing. Lastly, a dramatic increase in prevalence rates was identified between 2001 (32%) and 2009 (60%) for youth with autism spectrum disorder. In summary, psychopharmacologic prevalence doubled during the targeted decade in the state of Michigan, and variables outside of the scope of medical best practice were found to influence psychopharmacologic prescribing practices. Implications of study findings on future research are discussed.
590 $a School code: 0128.
650 4 $a Clinical psychology. $3 524863
650 4 $a Pharmaceutical sciences. $3 3173021
690 $a 0622
690 $a 0572
710 2 $a Michigan State University. $b School Psychology - Doctor of Philosophy. $3 3189616
773 0 $t Dissertation Abstracts International $g 77-10B(E).
790 $a 0128
791 $a Ph.D.
792 $a 2016
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=10109765